Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01814176
Other study ID # 11-0229-B
Secondary ID
Status Completed
Phase N/A
First received March 15, 2013
Last updated December 6, 2016
Start date July 2011
Est. completion date June 2012

Study information

Verified date March 2013
Source University Health Network, Toronto
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

During Anesthesia many patients require that a breathing be inserted into their windpipe. This is usually achieved using a direct laryngoscope, consisting of a retraction blade with a light near its end. When achieving a direct line-of-sight to the windpipe is difficult, more force is often applied, resulting in greater patient stress. A GlideScope video laryngoscope uses a camera and light source to see the windpipe. This enables the user to see objects that may not be in the direct line-of-sight. This likely results in less force being required, reducing patient stress. Because such stresses are often confounded by patient variables, we are comparing the forces required by the direct and video laryngoscopes on patients with at least one risk factor for difficulty, by directly measuring these with special sensors attached to the laryngoscope blades.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age > 18years

- elective surgery

- single lumen endotracheal intubation required

- signed informed consent

- one risk factor for a difficult laryngoscopy ( Mallampati score >3, inter-incisor gap < 3.5cm, thyromental distance < 6.5cm, sternomental distance < 12.5cm, reduced neck extension and flexion)

Exclusion Criteria:

- lack of patient consent

- anesthesiologist declines to consent

- contraindication to neuromuscular blockade

- ASA 4

- rapid sequence intubation

- previous failed intubation

- other method of intubation indicated eg fiberoptic intubation, awake tracheostomy

- symptomatic gastro-esophageal reflux

- cervical spine instability

- unstable hypertension and symptomatic coronary artery disease

- cerebrovascular disease or raised intracranial pressure

- oral/pharyngeal/laryngeal carcinoma

- loose teeth/poor dentition

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Intubation with GlideScope Video Laryngoscope or Macintosh Direct Laryngoscope


Locations

Country Name City State
Canada Toronto General Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak forces during intubation Peak forces generated during the laryngoscopy and intubation process using both laryngoscopes. Intraoperatively No